Study to evaluate the the effect of natalizumab discontinuation on cognitive functions in patients with relapsing remitting multiple sclerosis.
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.